FS Medical Supplies, LLC v. TannerGAP, Inc.

District Court, W.D. North Carolina·Decided April 2, 2024·No. 3:21-cv-00501·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NORTH CAROLINA CHARLOTTE DIVISION

FS MEDICAL SUPPLIES, LLC, ) ) Plaintiff, ) ) 3:21-cv-00501-RJC-WCM v. ) ) TANNERGAP, INC. and ) TANNER PHARMA UK LIMITED, ) ) Defendants. )

FS MEDICAL SUPPLIES, LLC ) ) Plaintiff, ) ) 3:23-cv-00598-RJC-WCM v. ) ) TANNER PHARMA UK LIMITED; ) RAYMOND FAIRBANKS BOURNE; ) and MARY EVERETT ) WHITEHURST BOURNE; ) ) Defendants. ) _______________________________ ) ORDER

This matter is before the Court on a Motion to Compel (Doc. 148) filed by FS Medical Supplies, LLC (“FSMS”).1

1 The motion was initially denied as moot following the filing of a stipulation by FSMS and the Bourne Defendants but was subsequently reinstated upon a consent motion and following a hearing. I. The Subject Discovery Dispute On September 20, 2023, FSMS filed its original complaint in FS Medical

Supplies, LLC v. Tanner Pharma UK Limited, Raymond Fairbanks Bourne, and Mary Everett Whitehurst Bourne, No. 3:23-cv-00598-RJC-WCM (“Tanner II”).2 Doc. 1. Generally, FSMS alleged that Raymond Fairbanks Bourne (“Mr. Bourne”) and Mary Everett Whitehurst Bourne (“Mrs. Bourne”) (collectively

the “Bourne Defendants”) fraudulently conveyed assets of Tanner Pharma UK Limited (“TPUK”) to the Bourne Defendants thereby “stripping the company of sufficient assets to pay FSMS.” Tanner II, Doc. 1, ¶ 1. The next day, FSMS filed a Motion for Temporary Restraining Order and Preliminary Injunction.

Tanner II, Doc. 5. On October 5, 2023, and as part of their opposition to that motion, the Bourne Defendants submitted a declaration of John Bly, a certified public accountant with the firm of Aprio, LLP (“Aprio”). Tanner II, Doc. 31. That

declaration stated, in part, that Bly had “worked with the Bournes on tax planning considerations related to the repatriation of dividends to them from [TPUK] for the tax years 2020, 2021 and 2022.” Id. at ¶ 2.

2 Tanner II has been consolidated for discovery purposes with FS Medical Supplies, LLC v. TannerGAP, Inc. and Tanner Pharma UK Limited, No. 3:21-cv-00501-RJC- WCM (“Tanner I”). The same day, FSMS filed an Amended Complaint. Tanner II, Doc. 33. That pleading includes a claim under N.C.G.S. §39-23.4(a) alleging in part that

Mr. Bourne caused TPUK to transfer at least $200 million to himself and Mrs. Bourne with the intent to hinder, delay, or defraud a creditor of TPUK. Doc. 33 at ¶¶ 29-32. The Bourne Defendants answered the Amended Complaint on October

26, 2023 and, in doing so, alleged that they had received dividends from TPUK “as a result of legitimate tax planning and for the payment of taxes owed by the Bournes.” Tanner II, Doc. 42 at 13. Subsequently, in their initial disclosures made pursuant to Rule

26(a)(1)(A), the Bourne Defendants indicated that Bly had information relating to the issuance of dividends from TPUK to the Bourne Defendants, the tax implications of issuing, or failing to issue, the dividends in dispute, the financial condition of TPUK at the time the dividends were issued, and the

financial condition of the Bourne Defendants. Tanner I, Doc. 149-1 at 2-3. On January 8, 2024, FSMS issued a document subpoena to Aprio and Bly (the “Subpoena”) that directed them to produce various materials in Charlotte, North Carolina. Tanner I, Doc. 149-4. Aprio and Bly have objected,

and FSMS has moved to compel their compliance with the Subpoena. II. Discussion Aprio and Bly have raised numerous objections, which are addressed in

turn, below. A. Service of the Motion to Compel Aprio and Bly initially object that the Motion to Compel itself was never served on them directly, as opposed to on their counsel. This objection is

without merit. After the Subpoena was served on Aprio and Bly, their attorney served an objection and response consisting of approximately 68 pages, and then communicated at length with FSMS’s counsel regarding the Subpoena. See

Tanner I, Doc. 149-7, Docs. 149-8 – 149-15. The certificate of service on the Motion to Compel indicates that the Motion was sent to counsel for Aprio and Bly. Counsel later filed a brief in opposition to the Motion to Compel and appeared during a video hearing on March 13, 2024 pertaining to a request by

FSMS that the Motion to Compel be reinstated. Aprio and Bly cite no provision of the Federal Rules of Civil Procedure that required FSMS to serve them directly with the Motion to Compel. Further, as a practical matter, Aprio and Bly (through their counsel) have had an

opportunity to respond to the Motion to Compel and have done so. B. Validity of the Subpoena Next, Aprio contends that the Subpoena is invalid on its face because it

attempts to require Aprio to produce documents at an improper location. Rule 45 of the Federal Rules of Civil Procedure provides, in relevant part, that a subpoena may command the “production of documents, electronically stored information, or tangible things at a place within 100 miles of where the

person resides, is employed, or regularly transacts business in person…” Fed. R. Civ. P. 45(c)(2). Aprio asserts that it is headquartered in Atlanta, Georgia, and therefore that the proper place of compliance is the Northern District of Georgia. It

argues that attempting to require it to produce documents in Charlotte, which is more than 100 miles away from Atlanta, is improper. See Tanner I, Doc. 157 at 9-12. In contrast, FSMS asserts that requiring Aprio to produce documents in

Charlotte is appropriate since Aprio regularly transacts business there. See Tanner I, Doc. 149 at 12-13. The view that the district where a company’s headquarters are located is a proper place of compliance is reasonable; because the corporation “resides,

is employed, or regularly transacts business in person…” where its headquarters are located, the company may be required to comply with a subpoena there. See e.g., Sec. & Exch. Comm'n v. TCA Fund Mgmt. Grp. Corp., No. 20-21964-CIV, 2021 WL 9440378, at *1 (S.D. Fla. June 10, 2021) (“Thus, the district of compliance for a nonparty corporation is typically where the

corporation is headquartered.”); Moore v. Pooches of Alrgo, Inc., No. 8:20-CV- 2184-MSS-SPF, 2023 WL 2584466, at *2 (M.D. Fla. Mar. 21, 2023) (“The district of compliance for a nonparty corporation is where the corporation is headquartered.”); Procaps S.A. v. Patheon Inc., No. 12-24356-CIV, 2015 WL

1722481, at *3 (S.D. Fla. Apr. 15, 2015) (“Subsection (c)(2)(A), in turn, defines the ‘place of compliance’ to be ‘within 100 miles of where the person resides, is employed or regularly transacts business in person.’ Because DSM is headquartered in Parsippany, N.J., this is the District of New Jersey.”)).

However, the text of Rule 45 does not limit the place of compliance solely to where a company is headquartered, and courts have declined to quash subpoenas that require compliance where companies regularly transact business, even if their corporate headquarters are located elsewhere. See e.g.,

Fed. Trade Comm'n v. Thomas Jefferson Univ., No. CV 20-01113, 2020 WL 4347371, at *2 (E.D. Pa. July 29, 2020) (“Kindred regularly transacts business within 100 miles of Philadelphia and there is no basis to quash the subpoena under Rule 45(d)(3)(A)(ii)); Trustees of Bos. Univ. v. Everlight Elecs. Co., No.

12-CV-11935-PBS, 2014 WL 12792496, at *3 (D. Mass. Sept.

Free access — add to your briefcase to read the full text and ask questions with AI

FS Medical Supplies, LLC v. TannerGAP, Inc., (W.D.N.C. 2024).

FS Medical Supplies, LLC v. TannerGAP, Inc. (FS Medical Supplies, LLC v. TannerGAP, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In re the Exxon Valdez
142 F.R.D. 380 (District of Columbia, 1992)